-
2 months ago | 
oncpracticemanagement.com | Dawn Holcombe |Diane Mapes |Sabrina Richards |Jan Hailey
By Diane Mapes; Sabrina RichardsA lab created a drug-matching platform that uses artificial intelligence (AI) to help researchers, clinicians and, most importantly, patients find additional uses for drugs that have already gone through clinical trials and received approval from the FDA. Read More ›Patient experience has become a cornerstone of medical office operations. It significantly influences patient outcomes, satisfaction, and overall well-being.
-
Nov 13, 2024 | 
oncpracticemanagement.com | Dawn Holcombe
The year 2024 has been tumultuous. Every one of our editorials explored a different way that oncology practices faced new challenges to their patients’ access to the care they need and the resources that can ease the emotional and financial burdens of their treatment. Unfortunately, each of those topics discussed continues to present hurdles to our patients, even at the close of 2024.
Here is an update on 3 related issues that continue to plague safe, effective, and timely access to patient care.
-
Oct 15, 2024 | 
oncpracticemanagement.com | Dawn Holcombe |Colleen Hall |Makema Massey |PMI-Approved Instructor
Subscribe Today!
To sign up for our free e-Newsletter or print publications, please enter your contact information below.
-
Sep 16, 2024 | 
ctmirror.org | Dawn Holcombe
On August 8, Benjamin Oldfield, MD, posted an opinion about the need to stand up against Big Pharma’s war on health centers. I would like to address a different perspective on the issue, and how it affects patients in Connecticut.
-
Aug 13, 2024 | 
oncpracticemanagement.com | Dawn Holcombe |Jason Lockard |Katie Lawrence
Subscribe Today!
To sign up for our free e-Newsletter or print publications, please enter your contact information below.
-
Jul 19, 2024 | 
oncpracticemanagement.com | Dawn Holcombe |Jamie L. Claypool
Subscribe Today!
To sign up for our free e-Newsletter or print publications, please enter your contact information below.
-
Jul 14, 2024 | 
oncpracticemanagement.com | Dawn Holcombe
We are all concerned about the costs of healthcare and especially cancer care in the United States. Every day, patients and those who care for them face difficult questions about whether needed treatment will be affordable. As patients search for financial options, medical practices, health systems, and patient advocacy organizations may want to exercise increased simple diligence on options and referral opportunities that come to them offering to “help” patients.
-
Jun 27, 2024 | 
theoncologypharmacist.com | Dawn Holcombe |Charlie Dawson |Anne Rowe |Gail Thompson
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
May 13, 2024 | 
oncpracticemanagement.com | Dawn Holcombe |Katie Lawrence |Jan Hailey |Bettinna Signori
State legislators have been focusing on reducing drug costs deemed “unaffordable” for patients via prescription drug affordability boards (PDABs). However, PDABs allow government-appointed board members to make critical medical decisions on pricing and access to prescription drugs for a state’s patients—without consulting medical providers or individual patient information. It is critical that we advocate for our patients to ensure that they receive medically necessary medications.
-
Apr 14, 2024 | 
ctmirror.org | Dawn Holcombe
This year, the Connecticut General Assembly has held public hearings on several legislative proposals that have the potential to put patients’ access to life-saving drugs at risk. Perhaps the most egregious of these proposals is SB 8: An Act Concerning Drug Affordability, which includes policy proposals to establish a Prescription Drug Affordability Board (PDABs), drug importation from Canada and a 340B mandate.
